Contact this trialFirst, we need to learn more about you.
Prodrug
OBI-3424 for T-Cell Acute Lymphoblastic Leukemia
Recruiting1 awardPhase 2
Fort Dodge, Iowa
This trial looks at how well OBI-3424 works in treating patients with T-cell acute lymphoblastic leukemia that has come back or does not respond to treatment. OBI-3424 may reduce the amount of leukemia in the body.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service